Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Eukaryotic translation initiation factor 1A, X-chromosomal (eIF1A) is an essential protein that participates in the initiation phase of eukaryotic translation. It is a component of the 43S pre-initiation complex, mediating the recruitment of the 40S ribosomal subunit to the 5' cap of messenger RNAs and facilitating scanning for the start codon as well as assembly of the 80S initiation complex. Mutations in this factor are recurrent in certain cancers, including uveal melanoma and thyroid carcinoma[1][2][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Eukaryotic translation initiation factor 1A, X-chromosomal (eIF1A).